Anthera Pharmaceuticals Inc (NASDAQ:ANTH), today announced that it has completed the previously announced underwritten public offering of 3,833,334 shares of its common stock, offered …
Anthera Pharmaceuticals Inc (NASDAQ:ANTH) investors may have forgotten its 2013 drug study scandal that set the scientific community spinning, as well as …
